SP-MHCI-0633-3

Human MAGE 4 230-239, GVYDGREHTV

US$507.00

In stock

Description

About Human MAGE 4 230-239, GVYDGREHTV

The Human Melanoma-associated antigen (MAGE) 4 Peptide (IEDB: 95091) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Melanoma-associated antigen (MAGE) Peptide, H-GVYDGREHTV-OH (Uniprot: P43358 aa: 230-239) from JPT is produced under strict quality control and quality management.

Human MAGE 4 230-239, GVYDGREHTV - Specifications

  • Peptide sequence: H-GVYDGREHTV-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Melanoma, Lung cancer
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human MAGE 4 230-239, GVYDGREHTV

References:
Read References with JPT’s Antigen Peptides
Human MAGE 4 230-239, GVYDGREHTV has been described in:
Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma., Elife, 2020 (PMID: 32314731)
T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4., J Biol Chem, 2020 (PMID: 32532817)
Immunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens., Proteomics, 2018 (PMID: 29786170)

Documentation

Documentation for Human MAGE 4 230-239, GVYDGREHTV

Properties

Properties of Human MAGE 4 230-239, GVYDGREHTV

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Lung cancer, Melanoma
Layout: Freeze-dried in glass vial
Organism: Human
Protein Name: Melanoma-associated antigen (MAGE)
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human MAGE 4 230-239, GVYDGREHTV

Information Values
Sequence: H-GVYDGREHTV-OH
Specifications: 10mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote